ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist
(group practice)

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,343Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 161

$638K Total Retail Price of All Prescriptions

Rank: 15 out of 161

551 Patients Receiving at Least One Drug in Part D
45%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 551 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

28% of this provider’s 551 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 6,187 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $85 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
FUROSEMIDE 520 278 1 5
POTASSIUM CHLORIDE 500 229 2 9
HYDROCODONE-ACETAMINOPHEN 491 154 S3 3 1
AMLODIPINE BESYLATE 456 290 4 6
PRAVASTATIN SODIUM 431 197 5 15
METFORMIN HCL 378 194 6 19
SIMVASTATIN 325 227 7 2
OMEPRAZOLE 323 154 8 4
HYDROCHLOROTHIAZIDE 315 181 9 18
LISINOPRIL 267 142 10 3
ZOLPIDEM TARTRATE 249 63 11 20
METOPROLOL TARTRATE 230 105 12 7
LEVOTHYROXINE SODIUM 224 120 13 11
NEXIUM 211 91 14 22
GLIPIZIDE 202 132 15 59
TRAMADOL HCL 191 95 16 28
DIOVAN HCT 186 54 17 65
CITALOPRAM HBR 170 52 18 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 162 95 19 30
GABAPENTIN 149 77 20 10
WARFARIN SODIUM 143 78 21 12
PROMETHAZINE HCL 140 33 R 22 81
GLIPIZIDE ER 130 63 23 94
LOSARTAN-HYDROCHLOROTHIAZIDE 125 73 24 52
PANTOPRAZOLE SODIUM 124 49 25 51
CLONIDINE HCL 118 35 26 44
GLIMEPIRIDE 113 76 27 113
TRIAMTERENE-HCTZ 113 44 27 55
CARISOPRODOL 112 0 R 29 48
CIPROFLOXACIN HCL 111 49 30 39
AMOXICILLIN 109 36 31 218
CYCLOBENZAPRINE HCL 102 26 R 32 53
MELOXICAM 102 61 32 24
KLOR-CON M20 101 60 34 103
INSULIN SYRINGE 101 48 34 130
METOLAZONE 93 23 36 273
LOSARTAN POTASSIUM 91 45 37 31
METOPROLOL SUCCINATE 88 51 38 14
SULFAMETHOXAZOLE-TRIMETHOPRIM 86 29 39 62
FLUTICASONE PROPIONATE 85 30 40 43
CARVEDILOL 84 64 41 8
ALLOPURINOL 84 51 41 66
AMLODIPINE BESYLATE-BENAZEPRIL 83 53 43 112
KLOR-CON M10 83 40 43 178
GLIPIZIDE XL 82 40 45 146
CLOPIDOGREL 75 50 46 13
ATORVASTATIN CALCIUM 73 55 47 21
ATENOLOL 73 39 47 26
AZITHROMYCIN 72 21 49 97
CRESTOR 72 31 49 34
LANTUS 62 11 51 114
DIGOXIN 62 46 51 25
GLYBURIDE-METFORMIN HCL 59 20 R 53 211
FENOFIBRATE 59 28 53 95
POLYETHYLENE GLYCOL 3350 55 24 55 61
ALENDRONATE SODIUM 55 41 55 68
PLAVIX 55 35 55 17
SYNTHROID 50 26 58 229
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.